Loading…
TEVA-SPIRONOLACTONE is a brand name for Spironolactone, supplied as a tablet. The medicine, its uses, side effects and dosage are the same regardless of brand.
Verbatim from this product's HC label. Tap a section to expand.
2 Table of Contents ..................................................................................................................... 2 PART 1: Healthcare Professional Information ..........................................................................
4 1 Indications ............................................................................................................................ 1 Pediatrics .........................................................................................................................
2 Geriatrics .......................................................................................................................... 5 2 Contraindications ..................................................................................................................
5 3 Serious Warnings and Precautions Box ................................................................................. 5 4 Dosage and Administration ...................................................................................................
2 Recommended Dose and Dosage Adjustment................................................................. 5 Missed Dose ....................................................................................................................
7 5 Overdose .............................................................................................................................. 8 6 Dosage Forms, Strengths, Composition and Packaging ..........................................................
8 7 Warnings and Precautions .................................................................................................... 9 General ...................................................................................................................................
9 Carcinogenesis and Genotoxicity ............................................................................................ 9 Cardiovascular ........................................................................................................................
9 Driving and Operating Machinery........................................................................................... 9 Endocrine and Metabolism ....................................................................................................
9 Hepatic/Biliary/Pancreatic...................................................................................................... 9 Monitoring and Laboratory Tests .........................................................................................
10 Neurologic ............................................................................................................................ 10 Reproductive Health .............................................................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Spironolactone in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
1 Special Populations......................................................................................................... 1 Pregnancy ....................................................................................................................
2. 3 Pediatrics ..................................................................................................................... 11 8 Adverse Reactions...............................................................................................................
1 Adverse Reaction Overview ............................................................................................ 5 Post-Market Adverse Reactions......................................................................................
13 9 Drug Interactions ................................................................................................................ 4 Drug-Drug Interactions ...................................................................................................
5 Drug-Food Interactions ................................................................................................... 6 Drug-Herb Interactions ...................................................................................................
7 Drug-Laboratory Test Interactions .................................................................................. 19 10 Clinical Pharmacology .......................................................................................................
1 Mechanism of Action .................................................................................................... 2 Pharmacodynamics ......................................................................................................
3 Pharmacokinetics ......................................................................................................... 20 11 Storage, Stability and DisposaL .........................................................................................
21 12 Special Handling Instructions ............................................................................................ 21 Part 2: Scientific Information .................................................................................................
22 13. Pharmaceutical Information............................................................................................. 22 14 Clinical Trials .....................................................................................................................
1 Clinical Trial by Indication ............................................................................................. 2 Comparative Bioavailability Studies..............................................................................
28 15 […]